Harold Edward Fleming - 10 Jun 2021 Form 3 Insider Report for CRISPR Therapeutics AG (CRSP)

Role: Director
Signature: /s/ Michael Esposito, attorney-in-fact
Issuer symbol: CRSP
Transactions as of: 10 Jun 2021
Transactions value $: $0
Form type: 3
Filing time: 14 Jun 2021, 17:32:55 UTC
Next filing: 10 Jun 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24.1: Power of Attorney attached No securities are beneficially owned.